New 'Period Pills' could let you skip the pregnancy test
NCT ID NCT07671989
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a two-pill combination (mifepristone and misoprostol) to bring on a late period without first confirming pregnancy. It involves 100 people who are at least 18, have regular periods, and are up to 21 days late. Participants take the pills and report satisfaction and whether their period returns within 4 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Mifepristone and misoprostol (a two-pill combination to bring on a late period)
What this could lead to
If successful, this could offer a new, more private option for people to manage a late period at home without needing to confirm pregnancy first.
What could go wrong
This is a small, early-phase study (100 people) and the pills may not always work. Also, if someone is pregnant, these pills will end the pregnancy, which may not be what they want.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENSTRUAL REGULATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Roanoke Health Center
RECRUITINGRoanoke, Virginia, 24017, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UCSF Advancing New Standards in Reproductive Health (ANSIRH)
ACTIVE_NOT_RECRUITINGOakland, California, 94612, United States